Design and Development of Polymer Based Micro-Composite Scaffold as a Platform for Drug Delivery System
[1]
Vishal Vijay Pande, Department of Pharmaceutics (PG), Sanjivani College of Pharmaceutical Education and Research, Pune University, Kopargaon, India.
[2]
Vipul Prahladbhai Patel, Vipul Prahladbhai Patel.
[3]
Sanjay R. Arote, Sanjay R. Arote.
[4]
Pramila S. Bhawar, Department of Pharmaceutics (PG), Sanjivani College of Pharmaceutical Education and Research, Pune University, Kopargaon, India.
[5]
Dhanashri Devendra Borawake, Department of Pharmaceutics (PG), Sanjivani College of Pharmaceutical Education and Research, Pune University, Kopargaon, India.
[6]
Vishal Vitthal Halnor, Department of Pharmaceutics (PG), Sanjivani College of Pharmaceutical Education and Research, Pune University, Kopargaon, India.
Present study was taken up to develop scaffolds from biodegradable polymeric system and also to develop a new and simple method for preparation of scaffold. Number of drug delivery systems are available today but there is no ideal drug delivery system which full-fill all requirements. Hence scaffold is ideal drug delivery system which gives more advantages over conventional drug delivery systems. Scaffolds loaded with Meloxicam were prepared by using quasi emulsion solvent diffusion method using Polylactic co-glycolic acid (PLGA) and Polylactic acid (PLA) biodegradable polymer which is non toxic in nature. The synthesized scaffolds we reanalyzed for particle size, production yield, entrapment efficiency, zeta potential, Fourier transform infrared spectroscopy (FT-IR), Scanning electron microscopy (SEM), X-ray diffraction analysis (XRD), Brunauer-Emmett-Teller (BET) analysis. The FT-IR spectroscopy shows characteristics peak for pure Meloxicam and scaffold. The SEM analysis confirms porous network of scaffold. Surface area of scaffold for drug entrapment was studied by BET analysis and shows the good surface area available for drug entrapment. Entrapment efficiency of scaffold was 91.15% and practical yield was 45.37%. The in-vitro dissolution study for scaffold shows high drug release up to 90%cumulative drug release (CDR) than pure drug which show upto 50% CDR after 6 hrs thus it shows that increased in solubility and dissolution of pure Meloxicam entrapped in scaffold.
Scaffold, Tissue Engineering, Drug Delivery System, Meloxicam
[1]
Gaikwad V, Patil A. Gaikwad M. Scaffolds for drug delivery in tissueengineering. IJPSN 2008; 1 (2): 113-122.
[2]
Chesnutt BM, Viano AM, Yuan Y, Yang Y, Guda T, Mark R et al. Design and characterization of a novel chitosan/ nanocrystalline calcium phosphate composite scaffold for bone regeneration, J Biomed Mater Res PART A 2009; 88 (2): 491-502.
[3]
Di Silvio L, Bonfield W. Biodegradable drug delivery system for the treatment of bone infection and repair. J Mater Sci Mater Med 1999; 10: 653-658.
[4]
Shinto Y, Uchida A, Korkusuz F, Araki N, Ono K. Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. J Bone JtSurg 1992; 74-B (4): 600-604.
[5]
Gittens SA, Uludag H. Growth factor delivery for bone tissue engineering. J Drug Target 2001: 9; 407-29.
[6]
Tabata Y. Necessity of drug delivery systems to tissue engineering. In: Park KD, editor. Biomaterials and drug delivery toward the new millennium. Seoul: Han Rim Won Publisher 2000: 531.
[7]
Locaa D, Locs J, Selma K, Gulbis J, Salma I, Berzina-Cimdina L. Porous hydroxyapatite bioceramic scaffolds for drug delivery and bone regeneration. Mat Sci Eng 2011; 18: 1-4.
[8]
Zhao X, Kimb J, Christine AC, Nathaniel H, Kangwon L, Kamal B et al. Active scaffolds for on-demand drug and cell delivery. PNAS 2011; 108 (1): 67-72.
[9]
Hossana J, Gafurb MA, Kadirb MR, Karima MM, Preparation and characterization of gelatin-hydroxyapatite composite for bone tissue engineering. IJET-IJENS 2014; 14 (01): 24-32.
[10]
Abd RI, Ahmad SNF, Abdul R WAW. Biodegradable polymers and their bone applications: a review. IJBAS-IJENS. 2012; 12: 1.